FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2326504873> ?p ?o ?g. }

• W2326504873 endingPage "966" @default.
• W2326504873 startingPage "961" @default.
• W2326504873 abstract "To determine the frequency of and risk factors for major adverse drug reactions (MADRs) associated with anti-tuberculosis treatment at a tuberculosis (TB) referral hospital in the Republic of Korea.Data from an ongoing natural history cohort study were analyzed for permanent regimen changes due to adverse drug reactions and confirmed by chart review.Among 655 subjects, there were 132 MADRs in 112 (17%) subjects. The most common MADRs were gastrointestinal (n = 53), musculoskeletal (n = 22), psychiatric (n = 10), visual (n = 9) and peripheral neuropathic (n = 8). MADRs were more frequent in subjects being treated with second-line regimens (16%) compared to first-line regimens (2.5%). Drugs frequently associated with MADRs were amikacin (3/10, 30%), linezolid (8/29, 28%), para-aminosalicylic acid (47/192, 24%), pyrazinamide (31/528, 5.8%), macrolides (2/44, 4.5%) and cycloserine (12/272, 4.4%). Fluoroquinolones accounted for a single MADR (1/377, 0.003%), despite widespread usage. In multivariate analysis, infection with multi- or extensively drug-resistant disease and previous history of anti-tuberculosis treatment were risk factors for MADR, with adjusted hazard ratios of respectively 2.2 (P = 0.02) and 1.6 (P = 0.04).MADRs are common during anti-tuberculosis chemotherapy in this population, occurring in more than one in six subjects. New and less toxic agents to treat drug-resistant TB are urgently needed." @default.
• W2326504873 created "2016-06-24" @default.
• W2326504873 creator A5004063171 @default.
• W2326504873 creator A5005460851 @default.
• W2326504873 creator A5018322506 @default.
• W2326504873 creator A5024526886 @default.
• W2326504873 creator A5026919289 @default.
• W2326504873 creator A5028317116 @default.
• W2326504873 creator A5030384307 @default.
• W2326504873 creator A5031369165 @default.
• W2326504873 creator A5034824499 @default.
• W2326504873 creator A5047030256 @default.
• W2326504873 creator A5053950289 @default.
• W2326504873 creator A5056406805 @default.
• W2326504873 creator A5069790943 @default.
• W2326504873 creator A5071017673 @default.
• W2326504873 creator A5075061586 @default.
• W2326504873 creator A5075462954 @default.
• W2326504873 creator A5078464886 @default.
• W2326504873 creator A5083323416 @default.
• W2326504873 creator A5086152877 @default.
• W2326504873 creator A5087407245 @default.
• W2326504873 creator A5052548975 @default.
• W2326504873 date "2012-07-01" @default.
• W2326504873 modified "2023-10-01" @default.
• W2326504873 title "Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort" @default.
• W2326504873 cites W125328142 @default.
• W2326504873 cites W130933825 @default.
• W2326504873 cites W15229394 @default.
• W2326504873 cites W1968451120 @default.
• W2326504873 cites W1976180415 @default.
• W2326504873 cites W1981015386 @default.
• W2326504873 cites W2010783249 @default.
• W2326504873 cites W2012813414 @default.
• W2326504873 cites W2014321835 @default.
• W2326504873 cites W2082004384 @default.
• W2326504873 cites W2103230556 @default.
• W2326504873 cites W2109028417 @default.
• W2326504873 cites W2122450139 @default.
• W2326504873 cites W2124127309 @default.
• W2326504873 cites W2126623874 @default.
• W2326504873 cites W2128213745 @default.
• W2326504873 cites W2129445206 @default.
• W2326504873 cites W2130503164 @default.
• W2326504873 cites W2135353933 @default.
• W2326504873 cites W2145336665 @default.
• W2326504873 cites W2169246282 @default.
• W2326504873 cites W2186379012 @default.
• W2326504873 cites W2317920577 @default.
• W2326504873 cites W3145500172 @default.
• W2326504873 doi "https://doi.org/10.5588/ijtld.11.0574" @default.
• W2326504873 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6379909" @default.
• W2326504873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22584241" @default.
• W2326504873 hasPublicationYear "2012" @default.
• W2326504873 type Work @default.
• W2326504873 sameAs 2326504873 @default.
• W2326504873 citedByCount "48" @default.
• W2326504873 countsByYear W23265048732012 @default.
• W2326504873 countsByYear W23265048732014 @default.
• W2326504873 countsByYear W23265048732015 @default.
• W2326504873 countsByYear W23265048732016 @default.
• W2326504873 countsByYear W23265048732017 @default.
• W2326504873 countsByYear W23265048732018 @default.
• W2326504873 countsByYear W23265048732019 @default.
• W2326504873 countsByYear W23265048732020 @default.
• W2326504873 countsByYear W23265048732021 @default.
• W2326504873 countsByYear W23265048732022 @default.
• W2326504873 countsByYear W23265048732023 @default.
• W2326504873 crossrefType "journal-article" @default.
• W2326504873 hasAuthorship W2326504873A5004063171 @default.
• W2326504873 hasAuthorship W2326504873A5005460851 @default.
• W2326504873 hasAuthorship W2326504873A5018322506 @default.
• W2326504873 hasAuthorship W2326504873A5024526886 @default.
• W2326504873 hasAuthorship W2326504873A5026919289 @default.
• W2326504873 hasAuthorship W2326504873A5028317116 @default.
• W2326504873 hasAuthorship W2326504873A5030384307 @default.
• W2326504873 hasAuthorship W2326504873A5031369165 @default.
• W2326504873 hasAuthorship W2326504873A5034824499 @default.
• W2326504873 hasAuthorship W2326504873A5047030256 @default.
• W2326504873 hasAuthorship W2326504873A5052548975 @default.
• W2326504873 hasAuthorship W2326504873A5053950289 @default.
• W2326504873 hasAuthorship W2326504873A5056406805 @default.
• W2326504873 hasAuthorship W2326504873A5069790943 @default.
• W2326504873 hasAuthorship W2326504873A5071017673 @default.
• W2326504873 hasAuthorship W2326504873A5075061586 @default.
• W2326504873 hasAuthorship W2326504873A5075462954 @default.
• W2326504873 hasAuthorship W2326504873A5078464886 @default.
• W2326504873 hasAuthorship W2326504873A5083323416 @default.
• W2326504873 hasAuthorship W2326504873A5086152877 @default.
• W2326504873 hasAuthorship W2326504873A5087407245 @default.
• W2326504873 hasBestOaLocation W23265048732 @default.
• W2326504873 hasConcept C126322002 @default.
• W2326504873 hasConcept C141071460 @default.
• W2326504873 hasConcept C142724271 @default.
• W2326504873 hasConcept C197934379 @default.
• W2326504873 hasConcept C203014093 @default.
• W2326504873 hasConcept C2776297342 @default.
• W2326504873 hasConcept C2777975735 @default.

• next